Click here to get full coverage on If You Invested $1,000 in Grace Therapeutics, Inc (GRCE) - Stock Titan

If You Invested $1,000 in Grace Therapeutics, Inc (GRCE)  Stock Titan

If You Invested $1,000 in Grace Therapeutics, Inc (GRCE) - Stock Titan

Click here to get full coverage on GRCE Technical Analysis & Stock Price Forecast - intellectia.ai

GRCE Technical Analysis & Stock Price Forecast  intellectia.ai

GRCE Technical Analysis & Stock Price Forecast - intellectia.ai

Click here to get full coverage on Companies Like Grace Therapeutics (NASDAQ:GRCE) Are In A Position To Invest In Growth - simplywall.st

Companies Like Grace Therapeutics (NASDAQ:GRCE) Are In A Position To Invest In Growth  simplywall.st

Companies Like Grace Therapeutics (NASDAQ:GRCE) Are In A Position To Invest In Growth - simplywall.st

Click here to get full coverage on We Think Grace Therapeutics (NASDAQ:GRCE) Needs To Drive Business Growth Carefully - Yahoo Finance

We Think Grace Therapeutics (NASDAQ:GRCE) Needs To Drive Business Growth Carefully  Yahoo Finance

We Think Grace Therapeutics (NASDAQ:GRCE) Needs To Drive Business Growth Carefully - Yahoo Finance

Click here to get full coverage on Short Interest in Grace Therapeutics, Inc. (NASDAQ:GRCE) Grows By 300.8% - MarketBeat

Short Interest in Grace Therapeutics, Inc. (NASDAQ:GRCE) Grows By 300.8%  MarketBeat

Short Interest in Grace Therapeutics, Inc. (NASDAQ:GRCE) Grows By 300.8% - MarketBeat

Click here to get full coverage on GRCE Earning Date, Earning Analysis and Earning Prediction - intellectia.ai

GRCE Earning Date, Earning Analysis and Earning Prediction  intellectia.ai

GRCE Earning Date, Earning Analysis and Earning Prediction - intellectia.ai

Click here to get full coverage on Grace Therapeutics (GRCE) Advances Towards FDA Review with Promi - GuruFocus

Grace Therapeutics (GRCE) Advances Towards FDA Review with Promi  GuruFocus

Grace Therapeutics (GRCE) Advances Towards FDA Review with Promi - GuruFocus

Click here to get full coverage on Why some brain bleed patients miss full doses takes center stage at 2 meetings - Stock Titan

Why some brain bleed patients miss full doses takes center stage at 2 meetings  Stock Titan

Why some brain bleed patients miss full doses takes center stage at 2 meetings - Stock Titan

Click here to get full coverage on Analysts Are Bullish on Top Healthcare Stocks: Grace Therapeutics (GRCE), Alto Neuroscience, Inc. (ANRO) - The Globe and Mail

Analysts Are Bullish on Top Healthcare Stocks: Grace Therapeutics (GRCE), Alto Neuroscience, Inc. (ANRO)  The Globe and Mail

Analysts Are Bullish on Top Healthcare Stocks: Grace Therapeutics (GRCE), Alto Neuroscience, Inc. (ANRO) - The Globe and Mail

Click here to get full coverage on Grace Therapeutics, Inc. (NASDAQ:GRCE) Short Interest Update - MarketBeat

Grace Therapeutics, Inc. (NASDAQ:GRCE) Short Interest Update  MarketBeat

Grace Therapeutics, Inc. (NASDAQ:GRCE) Short Interest Update - MarketBeat

Click here to get full coverage on Grace Therapeutics, Inc. (NASDAQ:GRCE) Is Expected To Breakeven In The Near Future - Yahoo Finance

Grace Therapeutics, Inc. (NASDAQ:GRCE) Is Expected To Breakeven In The Near Future  Yahoo Finance

Grace Therapeutics, Inc. (NASDAQ:GRCE) Is Expected To Breakeven In The Near Future - Yahoo Finance

Click here to get full coverage on Craig-Hallum Maintains Grace Therapeutics(GRCE.US) With Buy Rating - Moomoo

Craig-Hallum Maintains Grace Therapeutics(GRCE.US) With Buy Rating  Moomoo

Craig-Hallum Maintains Grace Therapeutics(GRCE.US) With Buy Rating - Moomoo

Click here to get full coverage on Ethereum & Chainlink: A Structural Shift Toward Institutional Adoption - Binance

Ethereum & Chainlink: A Structural Shift Toward Institutional Adoption  Binance

Ethereum & Chainlink: A Structural Shift Toward Institutional Adoption - Binance

Click here to get full coverage on symbol__ Stock Quote Price and Forecast - CNN

symbol__ Stock Quote Price and Forecast  CNN

symbol__ Stock Quote Price and Forecast - CNN

Click here to get full coverage on Grace Therapeutics, Inc. (NASDAQ:GRCE): When Will It Breakeven? - simplywall.st

Grace Therapeutics, Inc. (NASDAQ:GRCE): When Will It Breakeven?  simplywall.st

Grace Therapeutics, Inc. (NASDAQ:GRCE): When Will It Breakeven? - simplywall.st

Click here to get full coverage on Grace Therapeutics (GRCE) Submits NDA for GTx-104 to FDA | GRCE Stock News - GuruFocus

Grace Therapeutics (GRCE) Submits NDA for GTx-104 to FDA | GRCE Stock News  GuruFocus

Grace Therapeutics (GRCE) Submits NDA for GTx-104 to FDA | GRCE Stock News - GuruFocus

Click here to get full coverage on April 23 FDA target date set for Grace’s GTx-104 aSAH drug - Stock Titan

April 23 FDA target date set for Grace’s GTx-104 aSAH drug  Stock Titan

April 23 FDA target date set for Grace’s GTx-104 aSAH drug - Stock Titan

Click here to get full coverage on GRCE: Looking Ahead to Acceptance - Yahoo Finance

GRCE: Looking Ahead to Acceptance  Yahoo Finance

GRCE: Looking Ahead to Acceptance - Yahoo Finance

Click here to get full coverage on Grace Therapeutics Secures $30M Funding After Phase 3 Success, FDA Filing Set for Novel Hemorrhage Drug - Stock Titan

Grace Therapeutics Secures $30M Funding After Phase 3 Success, FDA Filing Set for Novel Hemorrhage Drug  Stock Titan

Grace Therapeutics Secures $30M Funding After Phase 3 Success, FDA Filing Set for Novel Hemorrhage Drug - Stock Titan

Click here to get full coverage on Grace Therapeutics presents phase 3 trial results for aSAH treatment - Investing.com

Grace Therapeutics presents phase 3 trial results for aSAH treatment  Investing.com

Grace Therapeutics presents phase 3 trial results for aSAH treatment - Investing.com

Click here to get full coverage on GRCE Forecast — Price Prediction for 2026. Should I Buy GRCE? - intellectia.ai

GRCE Forecast — Price Prediction for 2026. Should I Buy GRCE?  intellectia.ai

GRCE Forecast — Price Prediction for 2026. Should I Buy GRCE? - intellectia.ai

Click here to get full coverage on Polygon RWA Tokenization Surpasses $1.14 Billion, Signaling Strong Institutional Momentum - Binance

Polygon RWA Tokenization Surpasses $1.14 Billion, Signaling Strong Institutional Momentum  Binance

Polygon RWA Tokenization Surpasses $1.14 Billion, Signaling Strong Institutional Momentum - Binance

Click here to get full coverage on GRCE: Initiating Coverage – From Confusion to Infusion - Zacks Small Cap Research

GRCE: Initiating Coverage – From Confusion to Infusion  Zacks Small Cap Research

GRCE: Initiating Coverage – From Confusion to Infusion - Zacks Small Cap Research

Click here to get full coverage on Grace Therapeutics: TD Cowen Assessment Prior to the PDUFA Verdict - Bitget

Grace Therapeutics: TD Cowen Assessment Prior to the PDUFA Verdict  Bitget

Grace Therapeutics: TD Cowen Assessment Prior to the PDUFA Verdict - Bitget

Click here to get full coverage on Grace Therapeutics Inc (GRCE) Live Share Price, Invest From India - INDmoney

Grace Therapeutics Inc (GRCE) Live Share Price, Invest From India  INDmoney

Grace Therapeutics Inc (GRCE) Live Share Price, Invest From India - INDmoney

Click here to get full coverage on Latest GRCE News - Grace Therapeutics to Present Data on the U... - Stock Titan

Latest GRCE News - Grace Therapeutics to Present Data on the U...  Stock Titan

Latest GRCE News - Grace Therapeutics to Present Data on the U... - Stock Titan

Click here to get full coverage on Grace Therapeutics, Inc. (GRCE) stock price, news, quote and history - Yahoo Finance Singapore

Grace Therapeutics, Inc. (GRCE) stock price, news, quote and history  Yahoo Finance Singapore

Grace Therapeutics, Inc. (GRCE) stock price, news, quote and history - Yahoo Finance Singapore

Click here to get full coverage on Grace Reports Clinical Trial Victory and Major Cash Infusion in Latest Earnings - Stock Titan

Grace Reports Clinical Trial Victory and Major Cash Infusion in Latest Earnings  Stock Titan

Grace Reports Clinical Trial Victory and Major Cash Infusion in Latest Earnings - Stock Titan

Click here to get full coverage on GRCE Stock Price and Chart — NASDAQ:GRCE - TradingView

GRCE Stock Price and Chart — NASDAQ:GRCE  TradingView

GRCE Stock Price and Chart — NASDAQ:GRCE - TradingView

Click here to get full coverage on Grace Therapeutics (GRCE) Stock Price, News & Analysis - MarketBeat

Grace Therapeutics (GRCE) Stock Price, News & Analysis  MarketBeat

Grace Therapeutics (GRCE) Stock Price, News & Analysis - MarketBeat

Click here to get full coverage on Should I buy Grace Therapeutics, Inc. (GRCE) - Zacks Investment Research

Should I buy Grace Therapeutics, Inc. (GRCE)  Zacks Investment Research

Should I buy Grace Therapeutics, Inc. (GRCE) - Zacks Investment Research

Click here to get full coverage on Grace Therapeutics (GRCE) Stock Forecast and Price Target 2026 - MarketBeat

Grace Therapeutics (GRCE) Stock Forecast and Price Target 2026  MarketBeat

Grace Therapeutics (GRCE) Stock Forecast and Price Target 2026 - MarketBeat

Click here to get full coverage on What is the current Price Target and Forecast for Grace Therapeutics, Inc. (GRCE) - Zacks Investment Research

What is the current Price Target and Forecast for Grace Therapeutics, Inc. (GRCE)  Zacks Investment Research

What is the current Price Target and Forecast for Grace Therapeutics, Inc. (GRCE) - Zacks Investment Research

Click here to get full coverage on Grace Therapeutics Announces Third Quarter 2026 Financial Results, Provides Business Update - The Manila Times

Grace Therapeutics Announces Third Quarter 2026 Financial Results, Provides Business Update  The Manila Times

Grace Therapeutics Announces Third Quarter 2026 Financial Results, Provides Business Update - The Manila Times

Click here to get full coverage on Grace Therapeutics (GRCE) Earnings Date and Reports 2026 - MarketBeat

Grace Therapeutics (GRCE) Earnings Date and Reports 2026  MarketBeat

Grace Therapeutics (GRCE) Earnings Date and Reports 2026 - MarketBeat

Click here to get full coverage on GRCE Forecast — Price Target — Prediction for 2027 - TradingView

GRCE Forecast — Price Target — Prediction for 2027  TradingView

GRCE Forecast — Price Target — Prediction for 2027 - TradingView

Click here to get full coverage on Grace Therapeutics announces name change and new ticker - Investing.com

Grace Therapeutics announces name change and new ticker  Investing.com

Grace Therapeutics announces name change and new ticker - Investing.com

Click here to get full coverage on Grace Therapeutics to Present Novel aSAH Treatment at Major January Healthcare Events - Stock Titan

Grace Therapeutics to Present Novel aSAH Treatment at Major January Healthcare Events  Stock Titan

Grace Therapeutics to Present Novel aSAH Treatment at Major January Healthcare Events - Stock Titan

Click here to get full coverage on Grace Therapeutics to Showcase Novel aSAH Treatment at Major ASHP Clinical Meeting Ahead of Phase 3 Data - Stock Titan

Grace Therapeutics to Showcase Novel aSAH Treatment at Major ASHP Clinical Meeting Ahead of Phase 3 Data  Stock Titan

Grace Therapeutics to Showcase Novel aSAH Treatment at Major ASHP Clinical Meeting Ahead of Phase 3 Data - Stock Titan

Click here to get full coverage on Grace Therapeutics Announces Financing of $30 Million - citybiz

Grace Therapeutics Announces Financing of $30 Million  citybiz

Grace Therapeutics Announces Financing of $30 Million - citybiz

Click here to get full coverage on DOGS Coin Price Prediction 2025-2028: A Bullish Outlook for Investors - Binance

DOGS Coin Price Prediction 2025-2028: A Bullish Outlook for Investors  Binance

DOGS Coin Price Prediction 2025-2028: A Bullish Outlook for Investors - Binance

Click here to get full coverage on SWIFT Chooses Ethereum Layer-2 Linea for Its 2025 Global Payments Pilot — Not XRP - Binance

SWIFT Chooses Ethereum Layer-2 Linea for Its 2025 Global Payments Pilot — Not XRP  Binance

SWIFT Chooses Ethereum Layer-2 Linea for Its 2025 Global Payments Pilot — Not XRP - Binance

Click here to get full coverage on 5 Altcoins with 100x Potential by 2026 As institutional investors continue to enter the cryptocurre - Binance

5 Altcoins with 100x Potential by 2026 As institutional investors continue to enter the cryptocurre  Binance

5 Altcoins with 100x Potential by 2026 As institutional investors continue to enter the cryptocurre - Binance

Click here to get full coverage on Acasti Announces Corporate Name Change to Grace Therapeutics, Inc. - GlobeNewswire

Acasti Announces Corporate Name Change to Grace Therapeutics, Inc.  GlobeNewswire

Acasti Announces Corporate Name Change to Grace Therapeutics, Inc. - GlobeNewswire

Click here to get full coverage on Prashant Kohli Net Worth (2026) - GuruFocus

Prashant Kohli Net Worth (2026)  GuruFocus

Prashant Kohli Net Worth (2026) - GuruFocus

Click here to get full coverage on Zamet 2 vs Rudar scores & schedule - Sofascore

Zamet 2 vs Rudar scores & schedule  Sofascore

Zamet 2 vs Rudar scores & schedule - Sofascore

Click here to get full coverage on How iSize is reducing the size of video and helping save the planet - The Independent

How iSize is reducing the size of video and helping save the planet  The Independent

How iSize is reducing the size of video and helping save the planet - The Independent

Click here to get full coverage on William A Haseltine Net Worth (2026) - GuruFocus

William A Haseltine Net Worth (2026)  GuruFocus

William A Haseltine Net Worth (2026) - GuruFocus

Click here to get full coverage on Brian D. Ford Net Worth (2026) - GuruFocus

Brian D. Ford Net Worth (2026)  GuruFocus

Brian D. Ford Net Worth (2026) - GuruFocus

Click here to get full coverage on Children’s Museum Moving Into Downtown St. Cloud - WJON

Children’s Museum Moving Into Downtown St. Cloud  WJON

Children’s Museum Moving Into Downtown St. Cloud - WJON

Click here to get full coverage on AfCFTA Secretariat Unveils Required Tools And Instruments For Trade - NewsGhana

AfCFTA Secretariat Unveils Required Tools And Instruments For Trade  NewsGhana

GRCE

Price Chart

Key Statistics

Technicals

About GRCE

Latest News

If You Invested $1,000 in Grace Therapeutics, Inc (GRCE) - Stock Titan

GRCE Technical Analysis & Stock Price Forecast - intellectia.ai

Companies Like Grace Therapeutics (NASDAQ:GRCE) Are In A Position To Invest In Growth - simplywall.st

Advanced Charts

Top Gainers

Top Losers